Translational Regenerative Medicine conference
6 Apr 2010
Venue:
Benton Convention Center, , 301 W. Fifth St.
Winston-Salem, North Carolina
USA
Contact: jon@regenerativemedicinefoundation.org
More information: www.regenerativemedicinefoundation.org/20.35.1/Translational_Conference_Agenda
The Translational Regenerative Medicine Forum is designed as the premiere event for leaders in regenerative medicine translation, representing academic and clinical research, regulatory and reimbursement policy, venture investment and biotechnology industry interests. In order to facilitate business development opportunities and investment, the meeting will feature a venture forum showcasing 15 regenerative medicine companies.
Tuesday, April 6 2010
8:30 a.m. – 5:00 p.m. Media Academy (invitation-only)
4:00 p.m. – 6:00 p.m. Conference Registration and Networking
6:00 p.m. – 7:30 p.m. Opening Reception
Wednesday, April 7 2010: Advancing the Field of Regenerative Medicine
7:30 a.m. – 8:30 a.m. Networking Breakfast
8:30 a.m. – 10:00 a.m. Introductory Remarks and Opening Panel
10:00 a.m. – 10:30 a.m. Networking Break
10:30 a.m. – 11:15 a.m. The Translational Imperative
11:15 a.m. – 12:00 p.m. Scientific Overview
12:00 p.m. – 12:30 p.m. Public Policy
12:30 p.m. – 2:00 p.m. Lunch Keynote: Regenerative Medicine and Healthcare
2:00 p.m. – 3:15 p.m. Regulatory and Reimbursement Panel
3:15 p.m. – 3:30 p.m. Networking Break
3:30 p.m. - 4:30 p.m. Scientific Discoveries
6:30 p.m. Gala Dinner
Thursday, April 8 2010: Advancing Business Models and Best Practices
7:30 a.m. – 8:30 a.m. Networking Breakfast
8:30 a.m. – 9:00 a.m. Regenerative Medicine and the U.S. Military
9:00 a.m. – 10:15 a.m. The Clinical Imperative
10:15 a.m. – 10:45 a.m. Networking Break
10:45 a.m. – 11:35 a.m. New Players in Regenerative Medicine
11:40 a.m. – 12:30 p.m. Best Practices Panel
12:30 p.m. – 2:00 p.m. Luncheon Keynote
2:00 p.m. – 3:30 p.m. The Art of Funding
3:30 p.m. – 6:00 p.m. Venture Forum (featuring 15 early and later-stage ventures)
Speakers represent the entire translational continuum from scientists to entrepreneurs to private equity funders to corporate business development executives, including those who influence healthcare, regulatory and reimbursement policy. The Translational Forum will feature the following industry groups and areas of interest:
* Corporate Venture
* Venture Capital
* Regenerative Medicine Ventures
* Pharmaceuticals
* Medical Devices
* Diagnostics
* Clinicians
* Disease Philanthropies
* U.S. Military
* Academic Research
* Healthcare Policy
* Regulators
* Reimbursement/Payer




